class = “cf”>
The UK Medicines and Health Products Regulatory Agency (MHRA) said the vaccine, also known as the Spikevax vaccine, is “safe and effective in this age group.”
“We welcome the news that Modernna’s vaccine has been approved as safe and effective for people aged 12 and over,” the Ministry of Health statement said. it has been said.
Anyone aged 16 to 17 and clinically vulnerable children aged 12 to 15 will be able to make an appointment this week for the previously approved Pfizer / BioNTech vaccine, the statement said.
The European Medicines Agency (EMA) approved the Spikevax vaccine for use in children aged 12 to 17 in the European Union (EU) in July.
This guide guides gastronomy enthusiasts